In this study, we identified SEPT9 and SEPT2 as GBM associate genes in our multi-omics analysis, and found that suppression of their expression in GMB cells can repress the pathogenesis and progression of GBM both in vitro and in vivo. The gene discussed is SEPTIN9; the disease is glioblastoma.